Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Literature DB >> 1721307

In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

A Zeevi¹, R Venkataramanan, V Warty, G Eiras, M Woan, K Abu-Elmagd, M Alessiani, A Jain, A J Demetris, T Zerbe.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Tacrolimus

Year: 1991 PMID： 1721307 PMCID： PMC2981805

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

15 in total

1. Assay of FK 506 in plasma.

Authors: E M Cadoff; R Venkataramanan; A Krajack; A S Jain; J J Fung; S Todo; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

2. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

Authors: A Zeevi; G Eiras; G Burckart; A Jain; A Kragack; R Venkataramanan; S Todo; J Fung; T E Starzl; R J Duquesnoy
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.

Authors: A Zeevi; G Eiras; C Kaufman; M Alessiani; A J Demetris; K Abu-Elmagd; A Jain; V Warty; R Venkataramanan; G Burckart
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066

4. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors: K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal: Transplantation Date: 1991-07 Impact factor: 4.939

5. A highly sensitive method to assay FK-506 levels in plasma.

Authors: K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

Review 6. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.

Authors: B D Kahan
Journal: Transplantation Date: 1985-11 Impact factor: 4.939

7. Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection.

Authors: T Weber; T Zerbe; C Kaufman; A Zeevi; R Kormos; R Hardesty; B Griffith; R J Duquesnoy
Journal: Transplantation Date: 1989-09 Impact factor: 4.939

8. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.

Authors: T G Mayer; A A Fuller; T C Fuller; A I Lazarovits; L A Boyle; J T Kurnick
Journal: J Immunol Date: 1985-01 Impact factor: 5.422

In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

1. Assay of FK 506 in plasma.

2. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

3. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.

4. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

5. A highly sensitive method to assay FK-506 levels in plasma.

Review 6. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.

7. Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection.

8. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.

9. Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection.

Review 10. Propagation and characterization of lymphocytes from transplant biopsies.

Review 1. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Review 2. Clinical pharmacokinetics of tacrolimus.